Monaghan Medical Corporation

What Monaghan Medical Corporation does

Monaghan Medical Corporation is a privately held, U.S.-based medical device company founded in 1981 and headquartered in Plattsburgh, New York. The company develops, manufactures, and distributes a portfolio of prescription-only aerosol drug delivery and respiratory management devices, including valved holding chambers (AEROCHAMBER family), breath-actuated nebulizers (AEROECLIPSE BAN family), oscillatory positive expiratory pressure devices (AEROBIKA OPEP), positive airway pressure devices (VERSAPAP), and peak flow meters (TRUZONE), supported by a state-of-the-art aerosol research laboratory. The flagship AEROVERSE system integrates OPEP, nebulizer, and PAP devices into eight FDA 510(k)-cleared configurations, with peer-reviewed clinical outcomes including a 28% reduction in moderate-to-severe COPD exacerbations and 39% reduction in post-operative readmissions.

The company's value proposition rests on clinically validated inhalation efficiency, biofilm-resistant device materials, and integrated combination therapy that avoids the performance losses typical when competitors' devices are used together. U.S. patents (including 6,904,908 and 7,201,165) protect core VHC technology, and ISO 13485/14001 certifications anchor the manufacturing and quality systems. The company earns revenue exclusively through hardware sales of prescription medical devices; pricing is not publicly disclosed and reimbursement depends on individual insurance plans.

Monaghan Medical goes to market through a horizontal, multi-channel model combining an enterprise field sales force of territory managers serving hospitals and respiratory therapists, retail pharmacy distribution for prescription dispensing, and durable medical equipment (DME) providers for home use. Customer segments span patients with asthma, COPD, bronchiectasis, and cystic fibrosis; prescribing clinicians and acute care facilities; and dispensing pharmacies/DMEs. The company maintains strong professional community ties, including 10 AARC Zenith Awards in the past 11 years (voted on by 47,000 respiratory therapists), and has ongoing evidence partnerships with academic centers including Montefiore/Einstein (NIH PRAGMATIC-S study) and Virginia Tech (NTM biofilm research). Current commercial scope is restricted to the United States, though the website references service to major pharmaceutical companies engaged in respiratory medicine globally.

Name

Monaghan Medical Corporation

Legal name

Monaghan Medical Corporation

Website

https://monaghanmed.com

Company type

Private

Founded year

1981

Operating status

Operating

Headcount range

101–250 employees

Short description

Monaghan Medical Corporation is a private U.S. medical device manufacturer, founded in 1981 and headquartered in Plattsburgh, New York, that designs and sells FDA-cleared aerosol drug delivery and airway clearance devices—including valved holding chambers, breath-actuated nebulizers, and OPEP systems—via prescription to patients with asthma, COPD, and bronchiectasis and to their clinicians.

Ownership category

akta.pro rank

Product category

Respiratory Medical Devices

NAICS

Surgical Appliance and Supplies Manufacturing (339113)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Nebulizers & Aerosol Drug Delivery Systems (HLAHAIAJ)

akta.pro secondary industries

Inhalation & Nebulization Devices (Nebulizers, Spacers, Inhaler Accessories) (HLAHAGAE), Noninvasive Ventilation Interfaces & Consumables (Masks, Tubing, Humidifiers, Filters) (HLAHAGAG)

Keywords

• Respiratory medical devices
• Aerosol drug delivery
• Airway clearance therapy
• Valved holding chambers
• Breath-actuated nebulizers

Headquarters

HQ city

Plattsburgh

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Respiratory Medical Device Sales: Monaghan Medical generates revenue through the manufacture and sale of respiratory medical devices including valved holding chambers, nebulizers, OPEP devices, and peak flow meters. Products are sold through territory managers, pharmacies, and durable medical equipment providers. All products require a prescription.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Core offering

Monaghan Medical Corporation develops, manufactures, and sells prescription-based respiratory medical devices for aerosol drug delivery and airway management. Its portfolio includes valved holding chambers, breath-actuated nebulizers, oscillatory positive expiratory pressure devices, positive airway pressure devices, peak flow meters, and specialty tracheostomy and mechanical ventilation accessories, marketed under brands such as AEROCHAMBER®, AEROECLIPSE®, AEROBIKA®, VERSAPAP®, TRUZONE®, and integrated AEROVERSE® system.

Product overview

Monaghan Medical Corporation is a global leader in respiratory health medical devices, offering a comprehensive portfolio of aerosol drug delivery devices, airway clearance systems, and respiratory monitoring products. The company's core offerings include valved holding chambers (AEROCHAMBER® family), breath-actuated nebulizers (AEROECLIPSE® BAN® family), oscillatory positive expiratory pressure devices (AEROBIKA® OPEP), and positive airway pressure devices (VERSAPAP®). The flagship AEROVERSE® System serves as an integrated platform combining these devices to provide eight unique therapeutic configurations, enabling clinicians to tailor respiratory therapy for hospital and home settings. The product portfolio also includes specialty products for tracheostomy and mechanical ventilation applications, peak flow meters (TRUZONE®), and educational tools. All core therapeutic devices are FDA 510(k) cleared and supported by clinical evidence.

Differentiator

Problem solved

Functional benefit

Brands

• AEROCHAMBER: Valved holding chamber (VHC) product line for inhaler support and improved medication delivery to lungs
• AEROBIKA
• AEROECLIPSE
• TRUZONE
• VERSAPAP
• AEROVERSE
• DOC MONAGHAN
• AEROGEAR
• OMB Compressor
• AEROVENT
• AEROTRACH
• MC 300

Products and services

• AEROVERSE® System

Quantifiable outcome

• 28% reduction in moderate-to-severe COPD exacerbations with AEROBIKA OPEP device use
• +5 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Four partnerships are on record, tiered core and minor.

• Montefiore Medical Center and Albert Einstein College of MedicinecoreStrategic or Co-development Partner · 1 January 2025Dr. Marina Reznik of Montefiore Medical Center and Albert Einstein College of Medicine received a $4.1 million NIH research grant for the PRAGMATIC-S study on school-based asthma management. Monaghan Medical products (AEROCHAMBER Plus Flow-Vu and AEROECLIPSE II BAN Nebulizer) are featured in the study as effective medication delivery devices supporting proper inhaler technique and asthma control in children.
• Dr. Joseph Falkinham, Virginia TechcoreStrategic or Co-development PartnerDr. Joseph Falkinham, Professor of Microbiology at Virginia Tech, conducted independent research testing whether NTM bacteria could form biofilms on Monaghan Medical devices. His study demonstrated that AEROBIKA OPEP and AEROECLIPSE XL R BAN Nebulizer devices resist Mycobacterium avium and do not form biofilms even under extreme exposure conditions. Findings were presented at the 6th World Bronchiectasis & NTM Conference (2023).
• American Association for Respiratory Care (AARC)coreOthersAARC is a 47,000-member professional organization for respiratory therapists. Monaghan Medical has won the AARC Zenith Award 10 times in 11 years, directly voted by respiratory therapists. The award recognizes quality equipment, accessibility, responsiveness, service record, truth in advertising, and support of the respiratory care profession.
• Meritain HealthminorOthersMeritain Health serves as the third-party administrator for Monaghan Medical Corporation's self-funded group health plan. They host machine-readable files with negotiated rates and historical allowed amounts in compliance with federal Transparency in Coverage regulations. Plan ID is 141552699.

Scale indicators3 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• PARI Medical: PARI manufactures jet nebulizers and aerosol drug delivery systems widely used in cystic fibrosis, COPD, and asthma — a direct product overlap with Monaghan's AEROECLIPSE BAN nebulizers and VHC-like accessories.
• Intersurgical: European-headquartered manufacturer of airway management and aerosol drug delivery devices. Competes with Monaghan in hospital respiratory therapy, particularly valved holding chambers and spacer/accessory categories.

Broad incumbents

• Philips Respironics: A large incumbent within Royal Philips that spans hospital ventilators, CPAP/BiPAP, and aerosol drug delivery. Overlaps with Monaghan in nebulization and airway clearance but operates as a broad hospital/home-care portfolio rather than a focused drug delivery specialist.
• Vyaire Medical: Global respiratory and anesthesia equipment company offering nebulizers, ventilators, and airway clearance devices across the same customer base served by Monaghan, including acute and home care settings.
• Omron Healthcare: Large consumer and clinical device manufacturer with a strong nebulizer portfolio (e.g., MicroAir, CompAIR). Competes with Monaghan in aerosol drug delivery but addresses a broader home consumer and consumer-electronics audience.
• Drive DeVilbiss Healthcare: Durable medical equipment manufacturer with a respiratory franchise covering nebulizers, suction, and oxygen therapy. Distributes through DME channels that overlap with Monaghan's pharmacy and DME provider network.
• ResMed: Global leader in sleep and respiratory care (CPAP, bilevel, ventilators). While focused on sleep-disordered breathing, ResMed's hospital-to-home respiratory strategy creates overlap on bundled respiratory franchises and chronic disease management.
• Teleflex (Respiratory portfolio): Diversified medical device company whose respiratory division supplies aerosol and airway management products in the acute care channel, overlapping with Monaghan's VERSAPAP and specialty hospital offerings.
• Smith's Medical (ICU Medical): Provides airway management, oxygen therapy, and aerosol drug delivery products in acute care settings. Overlaps with Monaghan's hospital-focused VERSAPAP device and specialty VHC products for tracheostomy applications.

Emerging players

• Inspiring Health (AerobiKA competitor OPEP): Smaller specialist in airway clearance products including OPEP devices, directly competitive with Monaghan's AEROBIKA franchise in the bronchiectasis and COPD airway clearance segment.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/monaghanmed
• Xx.com/monaghanmedical

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Monaghan Medical Corporation